Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer

Journal of Urology

Volumn 172, Issue 2, 2004, Pages 506-507

  Koivisto, Pasi A ^a   Hyytinen, Eija R ^a   Matikainen, Mika ^a   Tammela, Teuvo L J ^a   Ikonen, Tarja ^a   Schleutker, Johanna ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Germ line mutation; IGF type 2; Prostatic neoplasms; Receptor; Transcription factors

Indexed keywords

DNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CHROMOSOME 10P; DNA SEQUENCE; FINLAND; GENE; GENE MUTATION; GERM LINE; HUMAN; KLF6 GENE; KRUPPEL LIKE FACTOR 6 GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 3142618487     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000129242.88182.e1     Document Type: Article

References (14)

1. Narla, G., Heath, K. E., Reeves, H. L., Li, D., Giono, L. E., Kimmelman, A. C. et al: KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science, 294: 2563, 2001
2. Chen, C., Hyytinen, E. R., Sun, X., Helin, H. J., Koivisto, P. A., Frierson, H. F., Jr. et al: Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol, 162:1349, 2003
3. Ittmann, M.: Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res, 56: 2143, 1996
4. Ratziu, V., Lalazar, A., Wong, L., Dang, Q., Collins, C., Shaulian, E. et al: Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci USA, 95: 9500, 1998
5. Laub, F., Aldabe, R., Ramirez, F. and Friedman, S.: Embryonic expression of Kruppel-like factor 6 in neural and non-neural tissues. Mech Dev, 106: 167, 2001
6. Chen, H. K., Liu, X. Q., Lin, J., Chen, T. Y., Feng, Q. S. and Zeng, Y. X.: Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas. Ai Zheng, 21: 1047, 2002
7. Jeng, Y. M. and Hsu, H. C.: KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer, 105: 625, 2003
8. Yamashita, K., Upadhyay, S., Osada, M., Hoque, M. O., Xiao, Y., Mori, M. et al: Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell, 2: 485, 2002
9. Schleutker, J., Matikainen, M., Smith, J., Koivisto, P., Baffoe-Bonnie, A., Kainu, T. et al: A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. Clin Cancer Res, 6: 4810, 2000
10. Gross, E., Arnold, N., Goette, J., Schwarz-Boeger, U. and Kiechle, M.: A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet, 105: 72, 1999
11. http://www.ncbi.nlm.nih.gov/SNP/index.html. Accessed March 2, 2004
12. Schleutker, J., Baffoe-Bonnie, A. B., Gillanders, E., Kainu, T., Jones, M. P., Freas-Lutz, D. et al: Genome-wide scan for linkage in Finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-p26. Prostate, 57: 280, 2003
13. Simard, J., Dumont, M., Soucy, P. and Labrie, F.: Perspective: prostate cancer susceptibility genes. Endocrinology, 143: 2029, 2002
14. Karan, D., Lin, M. F., Johansson, S. L. and Batra, S. K.: Current status of the molecular genetics of human prostatic adenocarcinomas. Int J Cancer, 103: 285, 2003